Fischer BC, Drick N, Liu B, Riemann L, et al. B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma. Respir Res 2026 Apr 2. doi: 10.1186/s12931-026-03500.
PMID: 41928209